Cytokine profiles and virological markers highlight distinctive immune statuses, and effectivenesses and limitations of NAs across different courses of chronic HBV infection
CONCLUSION: The differential CK and virological markers may serve as potential indicators of distinct immune statuses in chronic HBV infection. They also underscore the varying efficacy and limitations of NAs antiviral therapies. This next step would to break new ground in the optimization of current anti-HBV treatment programs although this requires further research.PMID:37995395 | DOI:10.1016/j.cyto.2023.156442
Source: Cytokine - Category: Molecular Biology Authors: Lixin Xiao Kang Tang Ting Fu Xiaojie Yuan Samuel Seery Weilu Zhang Zhaohua Ji Zhen He Yan Yang Wenhua Zhang Wenling Jia Chunhui Liang Haitao Tang Fengmei Wang Yancheng Ye Lihua Chen Zhongjun Shao Source Type: research
More News: Antiviral Therapy | Cancer & Oncology | Carcinoma | Cirrhosis | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver | Liver Cancer | Molecular Biology | Urology & Nephrology | Virology